Stifel Financial Corp · SF · FY2025 Q4 · Calendar Q1 2026
Stifel reports record FY2025 and guides for further growth
The supplied analysis supports a constructive but conditional view: record FY2025 revenue, strong Wealth Management and investment-banking performance, adviser recruiting, and maintained FY2026 guidance provide evidence of operating momentum. The main tests are expense discipline, investment-banking capacity, fixed-income conditions, and whether the planned balance-sheet and platform investments translate into sustained growth.
Earnings scorecard
Reported versus consensusMarket reaction
prior-close to event-session closeAsk FN2 about SF FY2025 Q4
Transcript, numbers and history already loadedFree account. Your question opens in FN2 with this report's transcript and numbers attached.
Transcript intelligence
What changed
Compared with the supplied prior-quarter analysis, the company moved from a record Q3 2025 with positive momentum to a record FY2025 and a maintained FY2026 revenue outlook. The current analysis adds the SIA and European-equities divestitures to the guidance context, continued adviser-recruiting and balance-sheet priorities, and explicit concerns around compensation, fixed income, execution capacity, and advisory-fee competition.
Guidance delta
Management maintained guidance; FY2026 revenue guidance is $6–6.35 billion with lower compensation and non-compensation ratios.
Key takeaways
- FY2025 revenue reached $5.5 billion, up 11%, according to the supplied analysis.
- Wealth Management remained the main engine, with $3.5 billion of revenue and $552 billion in client assets.
- Institutional investment-banking revenue rose 50% year over year, while management highlighted adviser recruiting and balance-sheet growth.
Management priorities
- Increase recruiting spend and incentives to attract high-producing advisers.
- Pursue selective M&A advisory opportunities, especially in bank consolidation.
- Continue wealth-platform technology investments and use balance-sheet growth to support lending and venture-banking opportunities.
Follow SF with an agent that reads every filing, transcript, and price print. Free to start.
Try FN2 freeEarnings History
Analyst 52W Price Targets
Latest persisted target per named analyst; persisted previous close from FN2's market snapshot as of Oct 22, 2026. Not an FN2 forecast.
Firm-level rating actions
FMP grade actions identify the grading firm, not a named analyst.
| Firm | Rating | Prior rating | Action | Date |
|---|---|---|---|---|
| TD Cowen | Hold | Hold | Maintain | Oct 12, 2026 |
| UBS | Buy | Buy | Maintain | Oct 7, 2026 |
| JP Morgan | Neutral | Neutral | Maintain | Oct 6, 2026 |
| BMO Capital | Market Perform | Market Perform | Maintain | Oct 6, 2026 |
| Citizens | Market Outperform | Market Outperform | Maintain | Jan 12, 2026 |
| JMP Securities | Market Outperform | Market Outperform | Maintain | Oct 9, 2025 |
| Citigroup | Buy | Neutral | Upgrade | Jul 31, 2025 |
| Wells Fargo | Overweight | Overweight | Maintain | Jul 11, 2025 |
| Goldman Sachs | Neutral | Neutral | Maintain | Apr 3, 2025 |
| Wolfe Research | Peer Perform | Outperform | Downgrade | Jul 22, 2024 |
| Credit Suisse | Neutral | Neutral | Maintain | Apr 28, 2021 |
| Compass Point | Buy | Buy | Maintain | May 30, 2019 |
| Nomura | Buy | Buy | Maintain | Feb 1, 2018 |
| Nomura Instinet | Buy | Neutral | Upgrade | Jan 3, 2018 |
| Instinet | Buy | Neutral | Upgrade | Jan 3, 2018 |
| Macquarie | Outperform | Outperform | Maintain | Sep 9, 2016 |
| Susquehanna | Neutral | Neutral | Maintain | Jul 15, 2015 |
| MKM Partners | Buy | Buy | Maintain | Mar 19, 2015 |
| Raymond James | Outperform | Market Perform | Upgrade | Aug 28, 2013 |
| Sidoti & Co. | Buy | Buy | Maintain | Aug 19, 2013 |
| Davenport | Neutral | Buy | Downgrade | Jun 13, 2013 |
| Bank oferica | Neutral | Neutral | Maintain | May 10, 2012 |
| B of A Securities | Neutral | Neutral | Maintain | May 10, 2012 |
Named analyst price targets
Upside is calculated against the persisted previous close $66.41. FMP does not supply a rating on these named-analyst rows.
| Firm | Analyst | 52W target | Price when posted | Upside | Date |
|---|---|---|---|---|---|
| UBS | Michael Brown | $84 | $70.12 | +26.5% | Oct 7, 2026 |
| Capital One Financial | Analyst unavailable | $75 | $71.13 | +12.9% | Oct 6, 2026 |
| UBS | Analyst unavailable | $90 | $80.19 | +35.5% | Jul 23, 2026 |
| UBS | Michael Brown | $86 | $73.42 | +29.5% | Jul 8, 2026 |
| UBS | Analyst unavailable | $89 | $76.92 | +34.0% | Apr 8, 2026 |
| Stifel Nicolaus | Analyst unavailable | $92 | $86.13 | +38.5% | Jan 14, 2026 |
| Wolfe Research | Steven Chubak | $99.33 | $86.89 | +49.6% | Jan 7, 2026 |
| UBS | Michael Brown | $100 | $86.66 | +50.6% | Dec 11, 2025 |
| UBS | Analyst unavailable | $90 | $74.49 | +35.5% | Oct 9, 2025 |
| Stifel Nicolaus | Analyst unavailable | $87.33 | $73.99 | +31.5% | Oct 8, 2025 |
| Stifel Nicolaus | Analyst unavailable | $90 | $76.74 | +35.5% | Jul 31, 2025 |
| Wells Fargo | Michael Brown | $75.33 | $67.48 | +13.4% | Oct 24, 2024 |
| JMP Securities | Devin Ryan | $73.33 | $63.35 | +10.4% | Oct 9, 2024 |
| Citigroup | Christopher Allen | $68 | $61.94 | +2.4% | Sep 27, 2024 |
| Goldman Sachs | Alexander Blostein | $62.67 | $61.89 | -5.6% | Sep 25, 2024 |
| Stifel Nicolaus | Bill Katz | $59.33 | $54.94 | -10.7% | Jul 8, 2024 |
| Stifel Nicolaus | Analyst unavailable | $20.67 | $44.42 | -68.9% | Feb 7, 2023 |
| Stifel Nicolaus | Analyst unavailable | $46.67 | $44.42 | -29.7% | Feb 7, 2023 |
| Stifel Nicolaus | Analyst unavailable | $66 | $44.81 | -0.6% | Feb 3, 2023 |
| Stifel Nicolaus | Analyst unavailable | $62.29 | $20.05 | -6.2% | Feb 2, 2023 |
| Stifel Nicolaus | Analyst unavailable | $74.71 | $29.91 | +12.5% | Feb 1, 2023 |
| Stifel Nicolaus | Analyst unavailable | $62 | $41.84 | -6.6% | Jan 13, 2023 |
| JMP Securities | Analyst unavailable | $63.33 | $40.29 | -4.6% | Jan 10, 2023 |
| Stifel Nicolaus | Analyst unavailable | $33.33 | $40.29 | -49.8% | Jan 10, 2023 |
| Stifel Nicolaus | Analyst unavailable | $17.33 | $39.77 | -73.9% | Jan 3, 2023 |
| Stifel Nicolaus | Analyst unavailable | $50.67 | $39.8 | -23.7% | Jan 3, 2023 |
| Stifel Nicolaus | Analyst unavailable | $28.67 | $38.47 | -56.8% | Dec 22, 2022 |
| Stifel Nicolaus | Analyst unavailable | $60.67 | $38.25 | -8.6% | Dec 19, 2022 |
| Stifel Nicolaus | Analyst unavailable | $50.42 | $17.02 | -24.1% | Dec 19, 2022 |
| Stifel Nicolaus | Analyst unavailable | $54.67 | $38.25 | -17.7% | Dec 19, 2022 |
| Stifel Nicolaus | Analyst unavailable | $42.67 | $38.25 | -35.8% | Dec 19, 2022 |
| Stifel Nicolaus | Analyst unavailable | $30 | $38.25 | -54.8% | Dec 19, 2022 |
| Stifel Nicolaus | Analyst unavailable | $36 | $38.25 | -45.8% | Dec 19, 2022 |
| Stifel Nicolaus | Analyst unavailable | $56.67 | $38.25 | -14.7% | Dec 19, 2022 |
| Stifel Nicolaus | Analyst unavailable | $38 | $38.25 | -42.8% | Dec 19, 2022 |
| Stifel Nicolaus | Analyst unavailable | $51.14 | $25.51 | -23.0% | Dec 19, 2022 |
| Stifel Nicolaus | Analyst unavailable | $50.72 | $17.02 | -23.6% | Dec 19, 2022 |
| Stifel Nicolaus | Analyst unavailable | $19.33 | $40.17 | -70.9% | Dec 14, 2022 |
| Stifel Nicolaus | Analyst unavailable | $22 | $40.4 | -66.9% | Dec 14, 2022 |
| Stifel Nicolaus | Analyst unavailable | $65.33 | $40.69 | -1.6% | Dec 13, 2022 |
| Stifel Nicolaus | Analyst unavailable | $51.81 | $27.14 | -22.0% | Dec 12, 2022 |
| Stifel Nicolaus | Analyst unavailable | $18.67 | $40.03 | -71.9% | Dec 9, 2022 |
| Stifel Nicolaus | Analyst unavailable | $40 | $40.13 | -39.8% | Dec 8, 2022 |
| Stifel Nicolaus | Analyst unavailable | $50 | $41.03 | -24.7% | Dec 6, 2022 |
| Stifel Nicolaus | Analyst unavailable | $45.33 | $42.99 | -31.7% | Dec 2, 2022 |
| Stifel Nicolaus | Analyst unavailable | $32 | $43.07 | -51.8% | Dec 2, 2022 |
| Stifel Nicolaus | Analyst unavailable | $53.36 | $28.18 | -19.7% | Nov 30, 2022 |
| Stifel Nicolaus | Analyst unavailable | $53.33 | $42.28 | -19.7% | Nov 29, 2022 |
| Stifel Nicolaus | Analyst unavailable | $24 | $42.75 | -63.9% | Nov 28, 2022 |
| Stifel Nicolaus | Analyst unavailable | $26.67 | $41.73 | -59.8% | Nov 17, 2022 |
| Stifel Nicolaus | Analyst unavailable | $51.91 | $18.64 | -21.8% | Nov 17, 2022 |
| Stifel Nicolaus | Analyst unavailable | $69.81 | $29.14 | +5.1% | Nov 16, 2022 |
| Stifel Nicolaus | Analyst unavailable | $25.33 | $43.43 | -61.9% | Nov 14, 2022 |
| JMP Securities | Analyst unavailable | $68.67 | $43.15 | +3.4% | Apr 28, 2022 |
Track every rating change on SF the moment it posts. Free to start.
Start freeCompany context
Snapshot as of publicationStifel Financial Corp. operates as the bank holding company for Stifel, Nicolaus & Company, Incorporated that provides retail and institutional wealth management, and investment banking services to individual, corporations, municipalities, and institutions in the United States, the United Kingdom, Canada, and internationally. It operates in three segments: Global Wealth Management, Institutional Group, and Other.…
Historical context
All SF earningsFinancial Services peers this season
Latest reports in the same sector| Company | Quarter | EPS surprise | Market move | Headline |
|---|---|---|---|---|
| SF-PB Stifel Financial Corp. | FY2026 Q3 · Calendar Q4 2026 | +1.4% | — | Stifel Q3: Wealth Management Strength and New Venture-Banking Tools |
| CME CME Group Inc. | FY2026 Q3 · Calendar Q4 2026 | +1.0% | +0.2% | CME posts record Q3 volume as products and international growth expand |
| MCO Moody's Corporation | FY2026 Q3 · Calendar Q4 2026 | -2.6% | +1.2% | Moody’s Reaffirms Guidance as AI Financing Supports Q3 Growth |
| NTRS Northern Trust Corporation | FY2026 Q3 · Calendar Q4 2026 | +11.5% | +0.9% | Northern Trust posts 40% EPS growth as AI and digital assets expand |
| NTRSO Northern Trust Corporation | FY2026 Q3 · Calendar Q4 2026 | +11.1% | +0.2% | Northern Trust pairs strong Q3 growth with 6–7% Q4 revenue outlook |
| SEIC SEI Investments Company | FY2026 Q3 · Calendar Q4 2026 | — | +1.2% | SEI posts broad growth as ETFs and alternatives expand |
Latest beats and misses
Who reports nextBeat on EPS
Missed on EPS
- MCOFY2026 Q3 · October 21, 2026-2.6% EPS+1.2% move
- CCIFY2026 Q3 · October 21, 2026-2.5% EPS-3.1% move
- PACFY2026 Q3 · October 20, 2026-2.2% EPS+7.1% move
- AGNCZFY2026 Q3 · October 19, 2026-0.6% EPS+0.3% move
- AGNCLFY2026 Q3 · October 19, 2026-0.6% EPS-0.3% move
- AGNCOFY2026 Q3 · October 19, 2026-0.6% EPS+0.3% move
Get the SF recap when the next report posts
One email per quarter with the scorecard, the market reaction and what changed on the call. No account needed.
Sources
- Earnings call transcript and parsed analysis · 2026-05-11T10:29:34.698584+00:00
- FN2 earnings calendar · 2026-07-26T00:37:12.209961+00:00
- Polygon adjusted daily market bars · 2026-10-22T06:40:45.765959+00:00
- Financial Modeling Prep analyst price-target consensus and quote snapshot · 2026-10-22T06:40:45.763206+00:00
Methodology
Reported and consensus figures come from FN2's earnings event records. Market reaction and volume are calculated from daily adjusted bars around the event; abnormal move subtracts the SPY move over the same window.
Analyst target low, average, and high values are derived at request time from each named analyst's latest persisted FMP target. The current-price marker comes from FN2's persisted market snapshot. They are sell-side estimates, not an FN2 valuation or recommendation.
Transcript intelligence is a structured synthesis of the current and prior earnings-call analyses. Missing values stay missing and are never estimated.
By FN2 Research · Updated · As of 2026-10-22. For educational purposes only; not investment advice.